Lifevantage (NASDAQ:LFVN) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Lifevantage (NASDAQ:LFVN) announced its quarterly earnings results on Thursday. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01), FiscalAI reports. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%.

Lifevantage Stock Down 2.4%

Shares of LFVN stock traded down $0.16 on Thursday, reaching $6.45. The stock had a trading volume of 98,308 shares, compared to its average volume of 272,217. The firm’s 50-day moving average is $6.42 and its two-hundred day moving average is $5.83. The firm has a market capitalization of $81.40 million, a price-to-earnings ratio of 14.33 and a beta of 0.72. Lifevantage has a 12 month low of $3.90 and a 12 month high of $14.28.

Lifevantage Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend is Tuesday, September 1st. Lifevantage’s dividend payout ratio is presently 44.44%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Lake Street Capital lowered Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price for the company. in a research note on Thursday, May 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $5.00.

Hedge Funds Weigh In On Lifevantage

Several institutional investors and hedge funds have recently made changes to their positions in LFVN. Cubist Systematic Strategies LLC bought a new stake in shares of Lifevantage during the 1st quarter valued at $97,000. Jones Financial Companies Lllp lifted its stake in shares of Lifevantage by 14,484.0% in the 1st quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company’s stock valued at $425,000 after acquiring an additional 28,968 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Lifevantage by 24.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock worth $649,000 after buying an additional 8,762 shares during the period. Jane Street Group LLC increased its holdings in Lifevantage by 5.4% in the first quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock valued at $533,000 after purchasing an additional 1,877 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Lifevantage by 106.1% during the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after purchasing an additional 126,274 shares during the last quarter. Institutional investors and hedge funds own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.